Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza
Clinical trial NCT07095257 · COMPLETED
Trial details
- NCT number
- NCT07095257
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-13
- Primary completion
- 2026-01-16
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.